Unlearn.AI logo

Unlearn.AI

Emerging

Unlearn.AI raised $50M+ for its digital twin technology that creates AI-generated control arms for clinical trials, reducing placebo group size and accelerating drug development timelines.

Best for: Clinical TrialsEmerging, rapid growth
22
AI Score
Grade D↑ Trending
AI Visibility Score (Beta)
Artificial IntelligenceClinical TrialsWebsiteUpdated April 2026

Brand Intelligence Graph

Competes with
Capabilities
Clinical Trials

Company Overview

About Unlearn.AI

Unlearn.AI generates digital twins of clinical trial patients — AI models trained on historical trial data that predict how a specific patient would have responded as a placebo control. By supplementing small placebo control groups with these digital controls, pharmaceutical companies can run trials with fewer placebo patients (or none at all), reducing participant burden, trial costs, and development timelines without sacrificing statistical validity.

Business Model & Competitive Advantage

The company's PROCOVA methodology is the first FDA-qualified prognostic covariate method for clinical trials, giving it regulatory validation that underpins commercial adoption. Unlearn has partnered with major pharmaceutical companies including Sanofi and Roche and has digital twin programs active in multiple therapeutic areas including ALS, Alzheimer's, and multiple sclerosis.

Competitive Landscape 2025–2026

Founded in 2017 by machine learning researchers, Unlearn's approach sits at the intersection of AI and biostatistics, requiring both FDA regulatory expertise and cutting-edge generative modeling. As synthetic control arm approaches gain regulatory acceptance, Unlearn is positioned as the leading commercial provider of AI-augmented trial designs that make drug development faster, cheaper, and more ethical.

Founded
2017
Curated content • Fact-checked and verified

Key Differentiators

Emerging Innovator

Unlearn.AI is an emerging player bringing innovative solutions to the Enterprise AI market.

Frequently Asked Questions

Estimated Visibility Trend (Beta)

Simulated 8-week rolling score

22
↑ Trending

Based on estimated brand signals. Historical tracking coming soon.

Compare Unlearn.AI with Competitors

Side-by-side AI visibility scores, platform breakdown, and market position.

For Unlearn.AI

Claim This Profile

Are you from Unlearn.AI? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.

Claim Unlearn.AI Profile →
For competitors & analysts

Track AI Visibility in Real Time

Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Unlearn.AI vs competitors. Get alerts when AI recommendations shift.

Start Free Tracking →